April 20, 2021
The past 12 months been transformative for the life science industry in USA, and GBR explores how the funding environment has evolved to provide the influx of capital to sustain its innovations.
June 17, 2020
Robust M&A displays value despite pushback.
May 14, 2020
The moral imperative to innovate.
July 25, 2019
From New England to the Mid-Atlantic, a rising tide lifts all boats across the biopharma value chain.
May 23, 2019
Expert Opinion Article contributed by Jim Neal, CEO of the biotech enterprise XOMA.
April 24, 2019
Changing serialization requirements represent an opportunity for packaging companies that are looking to add value for their clients.
April 01, 2019
The U.S. biopharmaceuticals industry continues to grapple with the perennial issue of drug pricing.
February 27, 2019
Opportunities grow for contract service providers.
February 06, 2019
With biotechs now accounting for 70% of clinical trials in the United States, the VC private investment climate is heating up.
October 31, 2018
Large Pharma companies often turn to CMOs and CDMOs for specialized expertise, while Biotech startups rely upon their labs and hardware, resulting in a rapidly expanding and increasingly global business.